Effects of Anesthetic Ketamine on Anxiety-Like Behaviour in Rats
- 203 Downloads
There is scarce information regarding the effects of anesthetic doses of the non-competitive N-methyl-d-aspartate receptor antagonist ketamine on anxiety. The current study evaluated the acute effects of intraperitoneally (i.p.) administered anesthetic ketamine (100 mg/kg) i.p. on anxiety in rats. For this purpose, the light/dark and the open field tests were utilized. The effects of anesthetic ketamine on motility were also examined using a motility cage. In the light/dark test, anesthetic ketamine, administered 24 h before testing reduced the number of transitions between the light and dark compartments and the time spent in the light compartment in the rats compared with their control cohorts. In addition, ketamine was found to exert a depressive effect on rats’ motility. In the open field test, animals treated with anesthetic ketamine 24 h before testing spent essentially no time in the central area of the apparatus, decreased horizontal ambulatory activity, and preserved to a certain extent their exploratory behaviour compared to their control counterparts. The results suggest that, in spite of its hypokinetic effect, a single anesthetic ketamine administration apparently induces an anxiety-like state, while largely preserving exploratory behaviour in the rat. These effects were time-dependent they since they were extinguished when testing was carried out 48 h after anesthetic ketamine administration.
KeywordsAnesthetic ketamine Anxiety Rat
Compliance with Ethical Standards
Conflict of interest
The authors declare no potential conflicts of interest with respect to authorship and/or publication of this article.
Research Involving Animal Rights
All applicable international and national guidelines for the care and use of animals were followed.
- 2.Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist ketamine, in humans. Psychotomimetic, perceptual, cognitive and neuroendocrine responses. Archiv Gen Psychiatry 51:199–214CrossRefGoogle Scholar
- 5.Okon T (2007) Ketamine: an introduction for the pain and palliative medicine physician. Pain Phys 10:493–500Google Scholar
- 9.de Sousa FC, do Carmo de Oliveira Cito M, da Silva MI, Moura BA, de Aquino Neto MR, Feitosa ML, de Castro Chavez R, Macedo DS, de Vasconcelos SM, de Franca Fonteles MM, de Sousa FC (2010) Behavioraal alterations and pro-oxidant effect of a single ketamine administration in mice. Brain Res Bul 83:9–15CrossRefGoogle Scholar
- 12.Trevlopoulou A, Touzlatzi N, Pitsikas N (2016) The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats. Psychopharmacology 233:1045–1054CrossRefPubMedGoogle Scholar
- 20.Polissidis A, Galanopoulos A, Naxakis G, Papahatjis D, Papadopoulou-Daifoti Z, Antoniou K (2013) The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently. Int J Neuropsychopharmacol 6:1–11Google Scholar
- 23.Kirk RE. (1968) Experimental design: procedures for the behavioral science. Brooks/Cole, Belmont, CAGoogle Scholar